HUTCHMED (CHINA) LIMITED revenue breakdown overview

HUTCHMED (CHINA) LIMITED revenue for the last year amounted to 4.90 B HKD, the most of which — 2.12 B HKD — came from its highest performing source at the moment, Oncology/Immunology - Marketed Products, the year earlier bringing 1.29 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought HUTCHMED (CHINA) LIMITED 3.53 B HKD, and the year before that — 3.80 B HKD.